Cultural Impact of Prohibition Policies as Consequence of International Co-operation
In: Internationaler Drogenhandel und gesellschaftliche Transformation, S. 73-88
2115170 Ergebnisse
Sortierung:
In: Internationaler Drogenhandel und gesellschaftliche Transformation, S. 73-88
In: Foreign affairs: an American quarterly review, Band 79, Heft 5, S. 143
ISSN: 2327-7793
In: Defence and peace economics, Band 11, Heft 6, S. 643
ISSN: 1024-2694
In: NBER macroeconomics annual, Band 15, S. 339-390
ISSN: 1537-2642
In: Human rights quarterly, Band 21, Heft 1, S. 229-250
ISSN: 1085-794X
In: RUSI journal, Band 144, Heft 5, S. 28-33
ISSN: 0307-1847
In: Politische Vierteljahresschrift: PVS : German political science quarterly, Band 40, Heft 1, S. 221
ISSN: 0032-3470
In: The Reality of International LawEssays in Honour of Ian Brownlie, S. 199-224
In: Politische Vierteljahresschrift: PVS : German political science quarterly, Band 40, Heft 1, S. 218-219
ISSN: 0032-3470
In: Russian politics and law, Band 36, Heft 4, S. 64-76
ISSN: 1558-0962
In: Journal of development economics, Band 55, Heft 1, S. 133-153
ISSN: 0304-3878
In: Sociology: the journal of the British Sociological Association, Band 32, Heft 1, S. 141-162
ISSN: 1469-8684
The US drug regulatory authority, the Food and Drug Administration (FDA) is often thought to demand higher standards of consumer protection from drug manufacturers than its British counterparts, the Medicines Control Agency (MCA) and the Committee on the Safety of Medicines (CSM). Yet since 1991 the MCA has banned one of the most prescribed tranquillisers, Halcion, while it remains approved by the FDA and on the market in the United States. This article attempts to explain the Halcion anomaly and questions explanations proposed by previous sociological research in the field. Broad societal influences, such as the role of the mass media, the increasing threat of litigation regarding drug injury and deregulatory politics are considered to be unlikely explanations. Rather, microsociological processes concerning the internal organisation of the drug regulatory authorities and the interaction between that organisation and technical analyses of safety data are found to be the key explanatory factors.
In: Rural Society, Band 8, Heft 3, S. 269-284
ISSN: 2204-0536
In: Russian politics and law: a journal of translations, Band 36, Heft 4, S. 64-76
ISSN: 1061-1940
In: Australian journal of political science: journal of the Australasian Political Studies Association, Band 33, Heft 2, S. 299
ISSN: 1036-1146